EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Erythroferrone‐Driven Regulation of Hepcidin and Iron Levels in Polytransfused Sickle Cell Anaemia Patients: A Prospective Study

Samuel Kwasi Appiah iD, Charles Nkansah iD, Godfred Amoah Appiah, Gabriel Abbam iD, Felix Osei-Boakye iD, Samira Daud, Kofi Mensah, Safo Adwoa, Korah Seedolf Kuwaahsuore, Emmanuel Yeboah, Abu Siraj Salma Tiyumba, Dennis Thompson und 9 weitere

BioMed Research International · 2025-01 · 2025 (1)

DOI: 10.1155/bmri/6803051 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BioMed Research International, online erschienen am 27.03.2025. Verfasst von Samuel Kwasi Appiah und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, School of Allied Health Sciences, University for Development Studies, Tamale, Ghana. Hauptthemen laut MEDLINE: Hepcidins, Anemia, Sickle Cell, Iron. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interplay of erythroferrone (ERFE), hepcidin, and ferroportin is crucial for ensuring systemic iron homeostasis. This study determined the influence of ERFE on hepcidin and iron levels in polytransfused patients with sickle cell anaemia (SCA). This multicentre case‐control study recruited 60 SCA participants and 30 controls (HbA), aged 2–34 years, from Tamale Teaching Hospital; Methodist Hospital, Wenchi; and Seventh Day Adventist Hospital, Sunyani, Ghana, between the periods of March to July 2023. About 4 mL of blood was collected for a full blood count using a haematology analyzer and serum ERFE, hepcidin, ferroportin, and ferritin estimation using an enzyme‐linked immunosorbent assay. Data were analyzed using SPSS Version 26.0. ERFE ( p < 0.001), ferroportin ( p = 0.016), ferritin ( p < 0.001), serum iron ( p < 0.001), transferrin ( p = 0.001), soluble transferrin receptor (sTFR) ( p = 0.019), TWBC ( p < 0.001), and platelet ( p < 0.001) were significantly higher in SCA participants and hydroxyurea‐naïve participants than in the control group and hydroxyurea‐treated participants, respectively. Levels of hepcidin ( p < 0.001), red blood cell ( p < 0.001), haemoglobin ( p < 0.001), and haematocrit ( p < 0.001) were lower in the SCA and hydroxyurea‐naïve groups than in the control and hydroxyurea‐treated groups, respectively. An inverse correlation was observed between serum ERFE and hepcidin ( r = −0.391, p = 0.002) and hepcidin and ferroportin ( r = −0.266, p = 0.040), while ferritin ( r = 0.439, p < 0.001) and ferroportin ( r = 0.309, p = 0.016) showed a positive correlation with ERFE. No correlation was found between serum hepcidin and ferritin levels ( r = 0.025, p = 0.853). Again, participants with regular blood transfusions had significantly higher levels of ERFE ( p < 0.001) and ferritin ( p = 0.002) than those with rare and no transfusions per year. None of the SCA participants had done iron testing. In conclusion, the negative impact of ERFE on hepcidin levels may exacerbate the risk of iron burden, as evident by elevated iron levels in SCA patients and the need for regular monitoring of the iron status of polytransfused SCA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepcidinsAnemia, Sickle CellIronHumansMaleFemaleAdolescentChildAdultChild, PreschoolYoung AdultCase-Control StudiesProspective StudiesFerritinsBlood TransfusionFerroportinPeptide Hormones

Stichwörter der Autor:innen

erythroferroneferroportinhepcidinpolytransfused patientssickle cell anaemiavaso-occlusive crises

Substanzen

HepcidinsIronErfe protein, humanFerritinsFerroportinPeptide Hormones

Autor:innen und Institutionen

  • Department of Haematology, School of Allied Health Sciences, University for Development Studies, Tamale, Ghana.
  • Department of Medical Laboratory Science, Faculty of Health Science and Technology, Ebonyi State University, Abakaliki, Nigeria.
  • Department of Biomedical Laboratory Sciences, School of Allied Health Sciences, University for Development Studies, Tamale, Ghana.
  • Department of Medical Laboratory Technology, Faculty of Applied Science and Technology, Sunyani Technical University, Sunyani, Ghana.

ORCID-Profile: Samuel Kwasi Appiah, Charles Nkansah, Gabriel Abbam, Felix Osei-Boakye

Zitieren

APA

Appiah, S. K., Nkansah, C., Appiah, G. A., Abbam, G., Osei-Boakye, F., Daud, S., Mensah, K., Adwoa, S., Kuwaahsuore, K. S., Yeboah, E., Tiyumba, A. S. S., Thompson, D., Paula, V. M., Duibajia, L. A., Takyia, P., Kwarteng, F. A., Asiedu, O. O., Sukasorr, F. I., Kawuribi, V., …, & Chukwurah, E. F. (2025). Erythroferrone‐Driven Regulation of Hepcidin and Iron Levels in Polytransfused Sickle Cell Anaemia Patients: A Prospective Study. BioMed Research International, 2025(1). https://doi.org/10.1155/bmri/6803051

Vancouver

Appiah SK, Nkansah C, Appiah GA, Abbam G, Osei-Boakye F, Daud S, et al. Erythroferrone‐Driven Regulation of Hepcidin and Iron Levels in Polytransfused Sickle Cell Anaemia Patients: A Prospective Study. BioMed Research International. 2025;2025(1). doi:10.1155/bmri/6803051

BibTeX
@article{Appiah2025,
  author = {Appiah, Samuel Kwasi and Nkansah, Charles and Appiah, Godfred Amoah and Abbam, Gabriel and Osei-Boakye, Felix and Daud, Samira and Mensah, Kofi and Adwoa, Safo and Kuwaahsuore, Korah Seedolf and Yeboah, Emmanuel and Tiyumba, Abu Siraj Salma and Thompson, Dennis and Paula, Viel Mary and Duibajia, Louis Adda and Takyia, Peter and Kwarteng, Franklina Ataa and Asiedu, Obed Odame and Sukasorr, Firdaus Ibrahim and Kawuribi, Vincent and Ukwah, Boniface Nwofoke and Chukwurah, Ejike Felix},
  title = {Erythroferrone‐Driven Regulation of Hepcidin and Iron Levels in Polytransfused Sickle Cell Anaemia Patients: A Prospective Study},
  journal = {BioMed Research International},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/bmri/6803051}
}
Kostenlos starten →